Pharmarise Holdings Corporation

2796.T
Pharmaceutical Retailers
2026/10/14 17:52 Updated
Market Cap: $36.6M (¥5.8B)
Stock Price: $3.19 (¥504)
Exchange Rate: 1 USD = ¥158.23

Notice Regarding Shareholder Benefits

The contents of the fiscal 2026 shareholder benefits were resolved. Eligible shareholders are those who held 100 shares or more for at least one year as of November 30, 2026. Beneficiaries may select one of dental care products, a long-term storage food set, or gift certificates. Postcard dispatch for applications is scheduled for late February 2027, the application deadline is mid-April 2027, and shipment of benefits is planned between mid-April and mid-June 2027.

Importance:
Page Updated: October 14, 2026
IR Disclosure Date: October 14, 2026

Key Figures

  • Eligibility: 100 shares or more held for at least one year
  • Application period: Until around mid-April 2027
  • Shipment timing: Mid-April 2027 to mid-June 2027

AI要約

Overview of Shareholder Benefits

At today’s board meeting, the contents of the fiscal 2026 shareholder benefits were determined. Eligible shareholders are those recorded in the shareholder register as of November 30, 2026 who have held 100 shares or more for at least one year. Shareholders may choose one item from options 1–3. Items include Medicinal Toothpaste Dental Police DX (80g × 2 tubes), a one-day portion long-term storage food set, or company gift certificates worth 2,500 yen. The validity period for the benefits is until March 31, 2028.

Application, Delivery, and Future Procedures

Application postcards are scheduled to be mailed in late February 2027, with the application deadline around mid-April 2027. Shipment of the benefits is planned from mid-April to mid-June 2027. The long-term holding period requirement follows the criteria applied since fiscal 2019 (same as previous conditions). Shareholders are encouraged to continue long-term holdings.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Pharmarise Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →